TRADENAME Abbvie Pty Ltd
Product name
TRADENAME
Sponsor
Accepted date
Jan-2026
Active ingredients
trenibotulinumtoxinE
Proposed indication
TrenibotulinumtoxinE is proposed for the temporary improvement in adult patients of the appearance of moderate to severe severe frown lines between the eyebrows that are caused by the corrugator and/or procerus muscles. It is proposed as an occasional treatment or as a trial before starting BOTOX treatment.
Application type
A (new medicine)
Publication date
Jan-2026